CDT news & sentiment — CDT Equity Inc.

APR 2·Stock TitanMed

CDT (NASDAQ: CDT) expands at‑the‑market capacity to $76.1M under AGP pact

CDT (NASDAQ: CDT) has increased its at-the-market (ATM) offering capacity to $76.1 million under its Sales Agreement with A.G.P./Alliance Global Partners. This expansion from a prior capacity of $3.5 million was possible because the company's public float exceeded $75.0 million as of March 24, 2026, allowing it to utilize General Instruction I.B.1 of Form S-3. The company, which is an emerging growth and smaller reporting company, noted a last reported sale price of $5.10 per share on April 1, 2026.

FEB 3·Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

This article highlights 12 healthcare stocks experiencing significant price movements in Tuesday's pre-market session. It lists top gainers including Liminatus Pharma, CDT Equity, and DaVita, noting their percentage increases and market capitalizations. Conversely, it identifies key losers such as Armata Pharmaceuticals, Avanos Medical, and Kairos Pharma, detailing their respective percentage decreases and market values.

JAN 23·TipRanks

Conduit Pharmaceuticals Establishes New $25 Million Equity Facility

Conduit Pharmaceuticals (CDT) has secured a new $25 million equity line of credit facility through a directed stock purchase agreement with an institutional investor. This arrangement grants the company the option to sell common shares over three years, with proceeds intended for working capital and general corporate purposes. While it provides funding flexibility, it also carries the potential for future shareholder dilution.

$CDT

CDT (NASDAQ: CDT) expands at‑the‑market capacity to $76.1M under AGP pact

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Conduit Pharmaceuticals Establishes New $25 Million Equity Facility

News on $CDT